SAN DIEGO, Feb 22, 2005 /PRNewswire-FirstCall via COMTEX/ —ACADIA Pharmaceuticals Inc.(Nasdaq: ACAD) announced today that Uli Hacksell, Ph.D., Chief ExecutiveOfficer, will present at the following upcoming investor conferences:
* The Wells Fargo Securities HealthCare Conference on Tuesday, March 1,2005, at 10:00 a.m. Eastern Time at the St. Regis Hotel in New YorkCity.
* The SunTrust Robinson Humphrey Therapeutics Conference on Tuesday,March 1, 2005, at 3:15 p.m. Eastern Time at the Le Parker MeridienHotel in New York City.
* The Fourth Annual JMP Securities Annual Research Conference onWednesday, March 2, 2005, at 2:10 p.m. Pacific Time at The Ritz-Carlton in San Francisco.
Live webcasts of these presentations will be accessible on the company'swebsite, www.acadia-pharm.com, under the investors section and archivedrecordings will be available on the website through March 16, 2005.
About ACADIA Pharmaceuticals
ACADIA Pharmaceuticals is a biopharmaceutical company utilizing innovativetechnology to fuel drug discovery and clinical development of novel treatmentsfor central nervous system disorders. ACADIA currently has four drug programsin clinical development as well as a portfolio of preclinical and discoveryassets directed at large unmet medical needs, including schizophrenia,Parkinson's disease, neuropathic pain, and glaucoma. Using its proprietarydrug discovery platform, ACADIA has discovered all of the drug candidates inits product pipeline. ACADIA's corporate headquarters and biology researchfacilities are located in San Diego, California and its chemistry researchfacilities are located near Copenhagen, Denmark.
Contacts:
ACADIA Pharmaceuticals Inc.
Lisa Barthelemy, Director, Investor Relations
Thomas H. Aasen, Vice President and Chief Financial Officer
+1 858-558-2871
ir@acadia-pharm.com